Anti-beta-2 glycoprotein I IgG antibodies are autoantibodies that target a protein involved in regulating blood clotting, often measured in the evaluation of antiphospholipid syndrome (APS).
Antikörper gegen β2-Glykoprotein-I IgG is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
Antikörper gegen β2-Glykoprotein-I IgG becomes relevant when low-grade inflammation, immune activity, or recovery questions are part of the picture. It can help flag inflammatory context, but it does not map symptom severity on its own.
Antikörper gegen β2-Glykoprotein-I IgG does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Anti-beta-2 glycoprotein I IgG (aβ2-GPI IgG) antibodies are a type of antiphospholipid antibody that target beta-2 glycoprotein I, a protein involved in the coagulation pathway. These autoantibodies can disrupt normal clotting processes, potentially leading to an increased risk of blood clots (thrombosis) and pregnancy-related complications such as recurrent miscarriages.
Testing for aβ2-GPI IgG is part of the laboratory criteria for antiphospholipid syndrome (APS), along with anticardiolipin antibodies and lupus anticoagulant. It is often ordered when someone has unexplained thrombosis, recurrent pregnancy loss, or a systemic autoimmune disorder like lupus.
A value below the reference range (typically <7 U/mL, lab-dependent) is considered normal and does not support a diagnosis of antiphospholipid syndrome.
A positive or elevated level of anti-β2-GPI IgG antibodies may suggest an increased risk of thrombotic events or pregnancy complications and can be one of the laboratory criteria for APS. However, for a diagnosis, the finding must be confirmed on two separate occasions at least 12 weeks apart and be associated with relevant clinical features. Temporary positivity can occur due to infections or other transient factors.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
Antikörper gegen β2-Glykoprotein-I IgG becomes relevant when low-grade inflammation, immune activity, or recovery questions are part of the picture. It can help flag inflammatory context, but it does not map symptom severity on its own.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Anti-Beta-2 Glycoprotein I IgG (aβ2-GPI IgG) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
Normal levels are generally below 7 U/mL, but this threshold can vary by laboratory and assay method. Your report will indicate whether the result is considered negative or positive based on the lab's cut-off.
A positive result may be a marker of antiphospholipid antibodies and is associated with an increased risk of blood clots and pregnancy complications. It is one of the laboratory tests used to help diagnose antiphospholipid syndrome (APS), but must be interpreted alongside clinical history and other tests, and confirmed with repeat testing.
Yes, these antibody levels can fluctuate. For a diagnosis of APS, a positive test must be confirmed on at least two occasions, 12 weeks apart. Transient increases may occur during infections or other illnesses and do not necessarily indicate a chronic condition.
Antikörper gegen β2-Glykoprotein-I IgG does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
For many fatigue-related, inflammatory, hormonal, or recovery-linked markers, interpretation becomes stronger when symptoms, exertion response, and daily function are considered together.
Antikörper gegen β2-Glykoprotein-I IgG is rarely meaningful in isolation when fatigue, brain fog, or unstable capacity are central. The fatigue hub provides the broader lab-and-symptom context.
If symptoms worsen after activity with a delay, PEM often explains more than an isolated lab value alone.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
